标题
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
作者
关键词
-
出版物
CURRENT MEDICINAL CHEMISTRY
Volume 26, Issue 17, Pages 3026-3041
出版商
Bentham Science Publishers Ltd.
发表日期
2017-09-14
DOI
10.2174/0929867324666170830111531
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC
- (2016) Xinjuan Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors
- (2016) Frederique M. Poulet et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors
- (2016) Ryan Gentzler et al. Immunotherapy
- The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
- (2016) Yoshiro Itatani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- D-α-Tocopheryl polyethylene glycol succinate/Solutol HS 15 mixed micelles for the delivery of baohuoside I against non-small-cell lung cancer: optimization and in vitro, in vivo evaluation
- (2016) Hong-mei Yan et al. International Journal of Nanomedicine
- Atypical chemokine receptors in cancer: friends or foes?
- (2016) Matteo Massara et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Expression of C-X-C chemokine receptor type 7 in otorhinolaryngologic neoplasms
- (2016) T Tang et al. SINGAPORE MEDICAL JOURNAL
- Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
- (2016) Zhidong Wang et al. TUMOR BIOLOGY
- Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer
- (2016) Weidong Wu et al. Oncotarget
- MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway
- (2016) Wei Yuan et al. Oncotarget
- CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
- (2016) Diane Goltz et al. Oncotarget
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
- (2016) Wanyin Chen et al. Stem Cells International
- CAR T Cell Therapy: A Game Changer in Cancer Treatment
- (2016) Hilde Almåsbak et al. Journal of Immunology Research
- Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
- (2016) Fabrizio Marcucci et al. Frontiers in Oncology
- miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12
- (2015) Jian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer
- (2015) R Muralidharan et al. CANCER GENE THERAPY
- Diverse Targets of -Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse
- (2015) Y.-W. Chang et al. CANCER RESEARCH
- Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
- (2015) G. Bertolini et al. CANCER RESEARCH
- Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency
- (2015) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor
- (2015) Jesús M. Planesas et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
- (2015) Massimo Moro et al. Journal of Thoracic Oncology
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway
- (2015) CHI LU et al. ONCOLOGY REPORTS
- Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin
- (2015) YANG YANG et al. ONCOLOGY REPORTS
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists
- (2015) Margaret K. Callahan et al. SEMINARS IN ONCOLOGY
- CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers
- (2015) Ivana Fridrichova et al. Translational Research
- Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells
- (2015) Masoumeh Es-haghi et al. TUMOR BIOLOGY
- The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells
- (2015) Donatella Malanga et al. Oncotarget
- CXCR4 over-expression and survival in cancer: A system review and meta-analysis
- (2015) Hongli Zhao et al. Oncotarget
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Special Conference on Tumor Immunology and Immunotherapy: A New Chapter
- (2015) K. T. Byrne et al. Cancer Immunology Research
- AMD3100/CXCR4 Inhibitor
- (2015) Erik De Clercq Frontiers in Immunology
- Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
- (2015) Maria Vela et al. Frontiers in Immunology
- Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
- (2015) Lukas Pawig et al. Frontiers in Immunology
- Resveratrol suppresses vascular endothelial growth factor secretion via inhibition of CXC-chemokine receptor 4 expression in ARPE-19 cells
- (2015) HYEMIN SEONG et al. Molecular Medicine Reports
- IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
- (2015) Janani Panneerselvam et al. PLoS One
- Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
- (2015) Luisa Carbognin et al. PLoS One
- 4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis
- (2015) Tingfang Yi et al. Oncotarget
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells
- (2014) Chikato Koga et al. ANNALS OF SURGICAL ONCOLOGY
- Baohuoside I Suppresses Invasion of Cervical and Breast Cancer Cells through the Downregulation of CXCR4 Chemokine Receptor Expression
- (2014) Buyun Kim et al. BIOCHEMISTRY
- Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression
- (2014) Zhongxing Liang et al. BREAST CANCER RESEARCH AND TREATMENT
- Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer
- (2014) Q Yang et al. BRITISH JOURNAL OF CANCER
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- JNK Signaling Mediates EPHA2-Dependent Tumor Cell Proliferation, Motility, and Cancer Stem Cell-like Properties in Non-Small Cell Lung Cancer
- (2014) W. Song et al. CANCER RESEARCH
- Lung Cancer Stem Cells and Implications for Future Therapeutics
- (2014) Jing Wang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma
- (2014) Kina Miyoshi et al. HUMAN PATHOLOGY
- Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis
- (2014) S. P. Cavnar et al. Integrative Biology
- MiR-451 Suppresses Cell Proliferation and Metastasis in A549 Lung Cancer Cells
- (2014) Pin Yin et al. MOLECULAR BIOTECHNOLOGY
- Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
- (2014) Benoît Romain et al. Molecular Cancer
- Inhibition of Angiogenesis, Fibrosis and Thrombosis by Tetramethylpyrazine: Mechanisms Contributing to the SDF-1/CXCR4 Axis
- (2014) Xiaoxiao Cai et al. PLoS One
- High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer
- (2014) LUNQING WANG et al. Oncology Letters
- Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
- (2014) Donald Wong et al. BMC Urology
- The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance
- (2014) D. T. Fearon Cancer Immunology Research
- Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
- (2013) G O'Boyle et al. BRITISH JOURNAL OF CANCER
- Benzenesulfonamides: A Unique Class of Chemokine Receptor Type 4 Inhibitors
- (2013) Suazette Reid Mooring et al. ChemMedChem
- Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
- (2013) K. A. Hassan et al. CLINICAL CANCER RESEARCH
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
- (2013) Karin Williams et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non–Small Cell Lung Cancer Cells
- (2013) Young H. Choi et al. MOLECULAR CANCER RESEARCH
- MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway
- (2013) T Yu et al. ONCOGENE
- Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer
- (2013) ALYA A. AL ZOBAIR et al. ONCOLOGY REPORTS
- The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
- (2013) Xiaoyang Ling et al. PLoS One
- Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis
- (2013) Leyre Larzabal et al. PLoS One
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer stem cells in lung cancer: Evidence and controversies
- (2013) Muhammad Alamgeer et al. RESPIROLOGY
- CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
- (2013) Ori Wald et al. Theranostics
- CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2
- (2012) Manik C. Ghosh et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lung Cancer Stem Cells as a Target for Therapy
- (2012) Elieser Gorelik et al. Anti-Cancer Agents in Medicinal Chemistry
- Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: New insight into CXCR4–FC131 interactions
- (2012) Yasushi Yoshikawa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression
- (2012) Zhe Jin et al. BMC CANCER
- ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
- (2012) Cheng-Po Huang et al. CANCER LETTERS
- Lung cancer stem cells: Progress and prospects
- (2012) Amber Lundin et al. CANCER LETTERS
- Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy
- (2012) Toshio Kubo et al. CANCER SCIENCE
- BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
- (2012) M. R. Kuhne et al. CLINICAL CANCER RESEARCH
- Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
- (2012) Anup Kumar Singh et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Wnt Signaling Regulates Intermediate Precursor Production in the Postnatal Dentate Gyrus by Regulating Cxcr4 Expression
- (2012) Youngshik Choe et al. DEVELOPMENTAL NEUROSCIENCE
- Development of novel CXCR4-based therapeutics
- (2012) Amnon Peled et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016
- (2012) Yasushi Otani et al. FEBS LETTERS
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
- (2012) Astrid Drenckhan et al. JOURNAL OF SURGICAL RESEARCH
- In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer
- (2012) Duha Fahham et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy
- (2012) John D. O’Flaherty et al. Journal of Thoracic Oncology
- EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
- (2012) Sandeep Singh et al. Molecular Cancer
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
- (2012) Johan Lennartsson et al. PHYSIOLOGICAL REVIEWS
- Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells
- (2012) Shulin Zhang et al. PLoS One
- Development of a Unique Small Molecule Modulator of CXCR4
- (2012) Zhongxing Liang et al. PLoS One
- Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
- (2012) Stephanie J. Gros et al. PLoS One
- CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
- (2012) Filomena de Nigris et al. Recent Patents on Anti-Cancer Drug Discovery
- CXCR7 in tumorigenesis and progression
- (2012) Kai-Lin Hou et al. Chinese Journal of Cancer
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network
- (2011) M Fareh et al. CELL DEATH AND DIFFERENTIATION
- CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
- (2011) S. Liekens et al. CURRENT PHARMACEUTICAL DESIGN
- Down-Regulation of CXCL12 by DNA Hypermethylation and Its Involvement in Gastric Cancer Metastatic Progression
- (2011) Yu Zhi et al. DIGESTIVE DISEASES AND SCIENCES
- Chemokines in tumor development and progression
- (2011) Naofumi Mukaida et al. EXPERIMENTAL CELL RESEARCH
- Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression
- (2011) Byoungduck Park et al. INTERNATIONAL JOURNAL OF CANCER
- Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line
- (2011) Xiao-ping Chen et al. International Journal of Clinical Oncology
- CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
- (2011) Fabien M. Décaillot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation
- (2011) Ori Wald et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics
- (2011) Wei-Qi Nian et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thymoquinone Inhibits the CXCL12-Induced Chemotaxis of Multiple Myeloma Cells and Increases Their Susceptibility to Fas-Mediated Apoptosis
- (2011) Gamal Badr et al. PLoS One
- Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis
- (2011) Itaru Kato et al. PLoS One
- Boswellic Acid Suppresses Growth and Metastasis of Human Pancreatic Tumors in an Orthotopic Nude Mouse Model through Modulation of Multiple Targets
- (2011) Byoungduck Park et al. PLoS One
- Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer
- (2011) MENG WANG et al. Experimental and Therapeutic Medicine
- Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells
- (2010) Angeline Wei Ling Chua et al. BIOCHEMICAL PHARMACOLOGY
- Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
- (2010) C D Salcido et al. BRITISH JOURNAL OF CANCER
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- The role of chemokine receptor CXCR4 in lung cancer
- (2010) Tara Gangadhar et al. CANCER BIOLOGY & THERAPY
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells
- (2010) Han-Cheon Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
- (2010) Balraj Singh et al. CLINICAL & EXPERIMENTAL METASTASIS
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Chemokines as mediators of tumor angiogenesis and neovascularization
- (2010) Ellen C. Keeley et al. EXPERIMENTAL CELL RESEARCH
- CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
- (2010) Katia Beider et al. EXPERIMENTAL HEMATOLOGY
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cytokine-induced killer cells to hepatocellular carcinoma cells
- (2010) Xin Yu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Dipyrimidine Amines: A Novel Class of Chemokine Receptor Type 4 Antagonists with High Specificity
- (2010) Aizhi Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor
- (2010) Vivek R. Yadav et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- HGF upregulates CXCR4 expression in gliomas via NF-κB: implications for glioma cell migration
- (2010) Mine Esencay et al. JOURNAL OF NEURO-ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100
- (2009) T. Murakami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Blockade of X4-Tropic HIV-1 Cellular Entry by GSK812397, a Potent Noncompetitive CXCR4 Receptor Antagonist
- (2009) S. Jenkinson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology
- (2009) Lisa Y. Pang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Chemokines in tumor-associated angiogenesis
- (2009) Peter Arne Gerber et al. BIOLOGICAL CHEMISTRY
- Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells
- (2009) Daisuke Uchida et al. Molecular Cancer
- Plerixafor
- (2009) John F. DiPersio et al. NATURE REVIEWS DRUG DISCOVERY
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells and role of HDACs
- (2008) E Ridolfi et al. BRITISH JOURNAL OF CANCER
- Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
- (2008) Cimona V. Hinton et al. CLINICAL & EXPERIMENTAL METASTASIS
- Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers
- (2008) Myaing M Nyunt et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
- CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
- (2008) Patrick L. Wagner et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone
- (2008) S. R. Chinni et al. MOLECULAR CANCER RESEARCH
- A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
- (2008) Catherine Labbaye et al. NATURE CELL BIOLOGY
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now